13F HOLDINGS REPORT
Sarissa Capital Management LP
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0000899140-25-001320
Total Value
$180.4M
Positions
8
Other Managers
0
Confidential Omitted
No
Holdings (8)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | INNOVIVA INC | INVA | 2,816,022 | $51.4M | 28.49% |
| 2 | NEUROCRINE BIOSCIENCES INC | NBIX | 303,151 | $42.6M | 23.59% |
| 3 | CYTOKINETICS INC | CYTK | 588,357 | $32.3M | 17.93% |
| 4 | IRONWOOD PHARMACEUTICALS INC | IRWD | 15,919,435 | $20.9M | 11.56% |
| 5 | AMARIN CORP PLC | AMRN | 1,242,527 | $20.4M | 11.28% |
| 6 | LANTHEUS HLDGS INC | LNTH | 181,450 | $9.3M | 5.16% |
| 7 | REGENERON PHARMACEUTICALS | REGN | 4,190 | $2.4M | 1.31% |
| 8 | VOR BIOPHARMA INC | VOR | 25,399 | $1.2M | 0.69% |